Joi Dunbar
- Duvelisib, a PI3K-δ,γ inhibitor, in subjects with mild asthmaBy Tess Schmalbach, Rainard Fuhr, Muna Albayaty, Kerstin Allen, Mark Douglas, Joi Dunbar, Justin McLaughlin, Laura Alexander and Charlotte McKeeTess Schmalbach1Clinical Development, Infinity Pharmaceuticals, Cambridge, MA United StatesRainard Fuhr2Early Phase, PAREXEL, Berline, GermanyMuna Albayaty3Early Phase, PAREXEL, London, United KingdomKerstin Allen1Clinical Development, Infinity Pharmaceuticals, Cambridge, MA United StatesMark Douglas1Clinical Development, Infinity Pharmaceuticals, Cambridge, MA United StatesJoi Dunbar1Clinical Development, Infinity Pharmaceuticals, Cambridge, MA United StatesJustin McLaughlin1Clinical Development, Infinity Pharmaceuticals, Cambridge, MA United StatesLaura Alexander1Clinical Development, Infinity Pharmaceuticals, Cambridge, MA United StatesCharlotte McKee1Clinical Development, Infinity Pharmaceuticals, Cambridge, MA United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.